Table of Contents

company-logo

SCHOTT Pharma AG & Co. KGaA develops, produces, and sells drug containment solutions and delivery systems for injectable drugs to the pharmaceutical and biotechnology industries worldwide. The company offers polymer and glass syringes, ampoules, vials, and cartridges. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; and SCHOTT TOPPAC unique, a polymer container. The company's cartridge products comprise cartriQ, a pharmaceutical glass cartridge for peptide and protein-based injectables; cartriQ Large Volume, a pharmaceutical glass cartridge for large-volume injectables; Cartridges Double Chamber, a pharmaceutical glass cartridge for lyophilized drugs; Cartridges Break Resistant, a pharmaceutical glass cartridge; and TopLine and StandardLine cartridges. Its vial products include adaptiQ, a pharmaceutical glass vial for injectables; EVERIC pure, a pharmaceutical glass vial for unmatched drug stability; EVERIC care, a pharmaceutical glass vial for a pH range; EVERIC strong & smooth, a pharmaceutical glass vial for the filling line performance; SCHOTT Type I plus, a pharmaceutical glass vial for drug formulations; SCHOTT TopLyo, a pharmaceutical glass vial to avoid fogging for lyophilized drugs; and TopLine and StandardLine vials. Its ampoule products comprise Ampoules easyOPC, a pharmaceutical glass ampoule for ampoule opening; Ampoules Anti-Counterfeiting, a pharmaceutical glass ampoule for protection against drug counterfeiting; and StandardLine ampoules. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.

SCHOTT Pharma Dividend Announcement

• SCHOTT Pharma announced a annually dividend of €0.15 per ordinary share which will be made payable on . Ex dividend date: 2024-03-15
• SCHOTT Pharma annual dividend for 2024 was €0.15
• SCHOTT Pharma's trailing twelve-month (TTM) dividend yield is 0.56%
• SCHOTT Pharma's payout ratio for the trailing twelve months (TTM) is 15.02%

SCHOTT Pharma Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-03-15€0.15annually

SCHOTT Pharma Dividend per year

SCHOTT Pharma Dividend Yield

SCHOTT Pharma current trailing twelve-month (TTM) dividend yield is 0.56%. Interested in purchasing SCHOTT Pharma stock? Use our calculator to estimate your expected dividend yield:

SCHOTT Pharma Financial Ratios

P/E ratio27.04
PEG ratio0.18
P/B ratio5.30
ROE20.72%
Payout ratio15.02%
Current ratio1.41
Quick ratio1.06
Cash Ratio0.05

SCHOTT Pharma Dividend FAQ

Does SCHOTT Pharma stock pay dividends?
SCHOTT Pharma does not currently pay dividends to its shareholders.
Has SCHOTT Pharma ever paid a dividend?
No, SCHOTT Pharma has no a history of paying dividends to its shareholders. SCHOTT Pharma is not known for its dividend payments.
Why doesn't SCHOTT Pharma pay dividends?
There are several potential reasons why SCHOTT Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SCHOTT Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SCHOTT Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SCHOTT Pharma a dividend aristocrat?
SCHOTT Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SCHOTT Pharma a dividend king?
SCHOTT Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SCHOTT Pharma a dividend stock?
No, SCHOTT Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SCHOTT Pharma stocks?
To buy SCHOTT Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SCHOTT Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.